Screener
Inhibrx Biosciences, Inc. INBX Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Inhibrx Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The source filing: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 4:02 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0002007919-26-000027
| Line item | THREE MONTHS ENDEDMARCH 31, 2026 | THREE MONTHS ENDEDMARCH 31, 2025 |
|---|---|---|
| Net cash used in operating activities | (38,026) | (35,895) |
| Cash flows from investing activities | ||
| Purchase of property and equipment | — | (21) |
| Net cash used in investing activities | — | (21) |
| Cash flows from financing activities | ||
| Proceeds from the issuance of debt | 74,992 | 99,965 |
| Payment of fees associated with debt | — | (125) |
| Proceeds from the exercise of stock options | 471 | — |
Item 1. Financial Statements (unaudited)
FAQ
- What is Inhibrx Biosciences, Inc.'s investing cash flow?
- Inhibrx Biosciences, Inc. (INBX) reported investing cash flow of $0 in Q1 2026.
- How has Inhibrx Biosciences, Inc.'s investing cash flow changed year-over-year?
- Inhibrx Biosciences, Inc.'s investing cash flow increased by 100.0% year-over-year, from -$21K to $0.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.
Ask your AI about Inhibrx Biosciences, Inc.'s investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude